Fact CheckerSign in

NCT07333898Not yet recruiting

Digital Measurements of Motor and Voice Functions in FTD

Source: ClinicalTrials.gov · Last updated 28 Apr 2026

Brief summary (registry, in English)

The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with FTLD syndromes. Researchers at BioSensics and Johns Hopkins School of Medicine will use wearable sensors, computerized speech, psychomotor, and cognitive assessments to create outcome measures and digital biomarkers for FTLD syndromes. Researchers will deploy this digital health solution to monitor 20 patients with FTLD syndromes for 12 months with study visits every 3 months.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
20 (estimated)
First submitted
30 Dec 2025
Start date
1 Aug 2026
Primary completion date
31 Aug 2028
Lead sponsor
BioSensics
NCT number
NCT07333898

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 1 Aug 2026 to the primary completion date, 31 Aug 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
  • Individuals who have a history of frequent falls defined as more than 5 falls per month.

Who the study is looking for

  • Male and female participants aged 40 years or older with a clinical diagnosis of possible or probable FTLD syndrome phenotype.
  • Participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
  • Individuals eligible for inclusion must be able to comply with the protocol per the investigator's judgment and must have a caregiver or study partner who is willing and able to assist with all study-related procedures.

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.